The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19).
The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19).
复制标题
DOI:
10.3390/ijms21176412
复制
发表时间:
2020-09-03
影响因子:
5.6
通讯作者:
Yu AM
中科院分区:
文献类型:
--
作者:
Batra N;De Souza C;Batra J;Raetz AG;Yu AM
The coronavirus disease of 2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global pandemic with increasing incidence and mortality rates. Recent evidence based on the cytokine profiles of severe COVID-19 cases suggests an overstimulation of macrophages and monocytes associated with reduced T-cell abundance (lymphopenia) in patients infected with SARS-CoV-2. The SARS-CoV-2 open reading frame 3 a (ORF3a) protein was found to bind to the human HMOX1 protein at a high confidence through high-throughput screening experiments. The HMOX1 pathway can inhibit platelet aggregation, and can have anti-thrombotic and anti-inflammatory properties, amongst others, all of which are critical medical conditions observed in COVID-19 patients. Here, we review the potential of modulating the HMOX1-ORF3a nexus to regulate the innate immune response for therapeutic benefits in COVID-19 patients. We also review other potential treatment strategies and suggest novel synthetic and natural compounds that may have the potential for future development in clinic.
登录
查看更多内容
影响因子:
37.3
作者:
Donati B;Lorenzini E;Ciarrocchi A
通讯作者:
Ciarrocchi A
影响因子:
15.9
作者:
Chung, Su Wol;Liu, Xiaoli;Perrella, Mark A.
通讯作者:
Perrella, Mark A.
影响因子:
5.3
作者:
Cobos EJ;Entrena JM;Nieto FR;Cendán CM;Del Pozo E
通讯作者:
Del Pozo E
影响因子:
15.9
作者:
Chen, Guang;Wu, Di;Ning, Qin
通讯作者:
Ning, Qin
影响因子:
12.7
作者:
Antony, Suresh J.;Davis, Michelle A.;Prakash, Bharat, V
通讯作者:
Prakash, Bharat, V